SESSION 1: Bench to Bedside:
Targeting Treatments for Global Access
Wednesday • November 20, 2024 • 9:15 AM–11:30 AM • Grand Ballroom
Moderator: Joanne Peart, Ph.D.
Inhaled Oxytocin: Addressing Challenges in Maternity Care in Low- and Middle-Income Countries
Pete Lambert & Jacob Harker
Monash University
Monash University
Practical Strategies to Improve Asthma Control in Resource Limited Settings
Mohamed Abdelrahim
Beni-Suef University
Beni-Suef University
Inhaled and Nasal Nano-formulations for Targeting Tuberculosis Therapy
Rahul Verma
Institute of Nano Science & Technology
Institute of Nano Science & Technology
Discover More
Inhalable Dry Powder Formulation of Voriconazole-Loaded Transferosomes for the Treatment of Invasive Pulmonary Aspergillosis
Vidya Viswanad
Amrita School of Pharmacy
Amrita School of Pharmacy
Development Of Peramivir-Loaded Dry Powder Inhalation Formulations For Respiratory Viral Infections
Aysu Yurdasiper Erdem
Ege University
Ege University
Anti-Tuberculosis Chemotherapy Via Pulmonary Route Using Electrosprayed Rifampicin-Loaded Chitosan Carriers
T S Sampath Kumar
Indian Institute of Technology Madras
Indian Institute of Technology Madras
Targeted Pulmonary Delivery Of Clofazimine Nano-in-Micro Particles For Tuberculosis Management
Krishna Jadhav
Institute of Nano Science & Technology
Institute of Nano Science & Technology
CO-ORGANIZERS
